Skip to main content
Clinical Trials/NCT02739230
NCT02739230
Completed
Not Applicable

Comparing Pain Relief Between Exparel® Injection vs. On-Q Catheter as the Postsurgical Analgesia Following Total Knee Arthroplasty (TKA)

Rothman Institute Orthopaedics0 sitesDecember 2013

Overview

Phase
Not Applicable
Intervention
Exparel
Conditions
Osteoarthritis: Joint Replacement Surgery
Sponsor
Rothman Institute Orthopaedics
Primary Endpoint
Total Morphine and morphine equivalent consumption
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The goal of this research project is to evaluate the effectiveness of a novel treatment to control pain after Total Knee Arthroplasty (TKA). The proposed approach to manage pain and eliminate risks associated with catheters is the use of Exparel injection into the joint at the time of surgery.

Registry
clinicaltrials.gov
Start Date
December 2013
End Date
October 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adults scheduled to undergo primary total knee replacement
  • Willing and able to provide informed consent

Exclusion Criteria

  • Not provided

Arms & Interventions

Exparel Injection

Intervention: Exparel

On-Q intraarthicual catheter placement

Intervention: On-Q pain intra-articular catheter

Outcomes

Primary Outcomes

Total Morphine and morphine equivalent consumption

Time Frame: 96 hours post-op

Similar Trials